“Early Phase I Results for 4-Demethyl-4-Cholesteryloxypenclo-Medine [DM-CHOC-PEN] As Therapy in Adolescent and Young Adult (AYA) Subjects With Advanced Malignancies ”. Journal of Cancer Research Updates, vol. 7, no. 3, Aug. 2018, pp. 75-78, https://doi.org/10.6000/1929-2279.2018.07.03.2.